Intracellular amyloid formation in muscle cells of Aβ-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification
Authors:
- Alicia N MinnitiAMAlicia N Minniti
- Daniela L RebolledoDRDaniela L Rebolledo
- Paula M GrezPGPaula M Grez
- Ricardo FadicRFRicardo Fadic
- Rebeca AldunateRARebeca Aldunate
- Irene VolitakisIVIrene Volitakis
- Robert A ChernyRCRobert A Cherny
- Carlos OpazoCOCarlos Opazo
- Colin MastersCMColin Masters
- Ashley I BushABAshley I Bush
- Nibaldo C InestrosaNINibaldo C Inestrosa
Open Access
- 6 January 2009
- journal article
- research article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 4 (1) , 2
Abstract
Background: The amyloid β-peptide is a ubiquitous peptide, which is prone to aggregate forming soluble toxic oligomers and insoluble less-toxic aggregates. The intrinsic and external/environmental factors that determine Aβ aggregation in vivo are poorly understood, as well as the cellular meaning of this process itself. Genetic data as well as cell biological and biochemical evidence strongly support the hypothesis that Aβ is a major player in the onset and development of Alzheimer's disease. In addition, it is also known that Aβ is involved in Inclusion Body Myositis, a common myopathy of the elderly in which the peptide accumulates intracellularly. Results: In the present work, we found that intracellular Aβ aggregation in muscle cells of Caenorhabditis elegans overexpressing Aβ peptide is affected by two single amino acid substitutions, E22G (Arctic) and V18A (NIC). Both variations show decrease intracellular amyloidogenesis compared to wild type Aβ. We show that intracellular amyloid aggregation of wild type Aβ is accelerated by Cu2+ and diminished by copper chelators. Moreover, we demonstrate through toxicity and behavioral assays that Aβ-transgenic worms display a higher tolerance to Cu2+ toxic effects and that this resistance may be linked to the formation of amyloid aggregates. Conclusion: Our data show that intracellular Aβ amyloid aggregates may trap excess of free Cu2+ buffering its cytotoxic effects and that accelerated intracellular Aβ aggregation may be part of a cell protective mechanism.Keywords
This publication has 74 references indexed in Scilit:
- The N‐terminal copper‐binding domain of the amyloid precursor protein protects against Cu 2+ neurotoxicity in vivoThe FASEB Journal, 2004
- Mixtures of Wild-type and a Pathogenic (E22G) Form of Aβ40 in Vitro Accumulate Protofibrils, Including Amyloid PoresJournal of Molecular Biology, 2003
- Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and IronJournal of Biological Chemistry, 2002
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001
- Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal DepletionJournal of Biological Chemistry, 1999
- Undetectable Intracellular Free Copper: The Requirement of a Copper Chaperone for Superoxide DismutaseScience, 1999
- The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's diseaseTrends in Cell Biology, 1998
- In Vivo Aggregation of β‐Amyloid Peptide VariantsJournal of Neurochemistry, 1998
- Rapid induction of Alzheimer A beta amyloid formation by zincScience, 1994
- A C. elegans mutant that lives twice as long as wild typeNature, 1993